December 13, 2021 — Qaelum NV announced that they enter into a strategic partnership withulrich GmbH & Co. KGin Ulm to combine their advanced Contrast Management solution with thecontrast media injectorsulrich医疗，以支持医院和影像网络的需求。对比剂量和辐射暴露是患者治疗中的每个参与者的问题，从患者，转诊医生，放射科和监管机构。The novel Contrast Management solution and Qaelum’s proven Dose Management System will enable organizations to manage, analyse and balance their contrast agents and the patient dose.
With this strategic alliance, ulrich medical will offer a flexible solution that allows for central recording and statistical data processing of the utilization of the connected contrast injectors at enterprise level. Contrast usage can be analyzed at different levels, protocols can be harmonized and regulatory reporting needs can be simplified. The vendor-neutral solution needs only a limited time investment of the local IT department and can run both in an on-premise or cloud-based version.
“Qaelum is a leader in Advanced Dose and Contrast Management software solutions,” said Sven Erdmann, Vice President Technology and Regulation of ulrich medical. “Our strategic alliance will allow medical imaging departments to take control over the usage of their contrast media injectors and provide them the tools to harmonize and optimize their injection protocols. By combining the strengths of the quality management tools of Qaelum, with the state-of-the-art solutions of ulrich medical, including our FDA approved DICOM RIS/PACS connection, we can now offer healthcare enterprises a complete solution that will help institutions drive more value from their existing investments, now and into the future.”
“We are delighted to enter into this strategic partnership with ulrich medical,” said Jurgen Jacobs, CEO and co-founder of Qaelum. “This partnership fits perfectly in our long term strategy to improve patient safety, quality and efficiency in medical imaging departments.
For more information:www.qaelum.com
August 12, 2022
